Skip to content

Performance evaluation of four prediction models for risk stratification in gastric cancer screening among a high-risk population in China

Performance evaluation of four prediction models for risk stratification in gastric cancer screening among a high-risk population in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043363
Enrollment
Unknown
Registered
2021-02-11
Start date
2016-10-01
Completion date
Unknown
Last updated
2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Case series:Nil

Sponsors

The First Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Aged >=18 years, regardless of gender; from Hangzhou City (Lin'an District), Jiaxing City (Nanhu District, Pinghu City, Haining City), Huzhou City (Anji County), Lishui City (Songyang County), Jinghua City (Yongkang City) , Yiwu City), Taizhou City (Luqiao District, Huangyan District, Jiaojiang District, Tiantai County), Shaoxing City (Keqiao District, Shangyu District), Zhoushan City (Dinghai District, Putuo District), Quzhou City (Qujiang District) and Ningbo City (Yinzhou District).

Exclusion criteria

Exclusion criteria: (1) Abdominal mass, hematemesis, and gastrointestinal bleeding; (2) unexplained weight loss > 5% of body weight in six months; (3) medical history of gastric surgery; (4) medical history of any type of cancers; (5) dysfunction in the liver, kidney, or the heart or severe cardiopulmonary diseases; (6) serious mental or psychiatric disorders; (7) taking proton pump inhibitors (PPIs) or H2 blockers at the time of screening for GC or within the two weeks; (8) taking anti-platelet drugs (e.g. aspirin) that may increase risk of gastrointestinal bleeding during endoscopic biopsy; and (9) pregnancy.

Design outcomes

Primary

MeasureTime frame
gastric cancer;

Countries

China

Contacts

Public ContactLu Bin

The First Affiliated Hospital of Zhejiang Chinese Medical University

drlvbin@163.com+86 13906515409

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 22, 2026